Published in Circulation on October 01, 1995
Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation (2009) 4.33
Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res (2004) 3.30
Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation (2008) 2.72
Familial aggregation in lone atrial fibrillation. Hum Genet (2005) 2.55
Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm (2010) 2.42
A noninvasive imaging modality for cardiac arrhythmias. Circulation (2000) 2.40
Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest (2011) 2.38
Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart (2004) 2.23
Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines. Circulation (2008) 2.20
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate. Circulation (2015) 2.12
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm (2008) 2.05
Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm (2009) 2.00
Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol (2013) 1.96
Managing atrial fibrillation in elderly people. BMJ (1999) 1.92
Heterogeneous atrial wall thickness and stretch promote scroll waves anchoring during atrial fibrillation. Cardiovasc Res (2012) 1.83
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation. Heart Rhythm (2010) 1.77
Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm (2008) 1.72
Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation (2013) 1.69
Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites. Cardiovasc Res (2007) 1.68
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res (2011) 1.65
TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation. Circ Res (2010) 1.65
Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol (2011) 1.63
Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation (2003) 1.57
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial). J Cardiovasc Electrophysiol (2010) 1.57
Spinal cord stimulation protects against atrial fibrillation induced by tachypacing. Heart Rhythm (2012) 1.49
Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study. Circulation (2015) 1.48
Multistage electrotherapy delivered through chronically-implanted leads terminates atrial fibrillation with lower energy than a single biphasic shock. J Am Coll Cardiol (2013) 1.45
Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts. Heart Rhythm (2013) 1.45
Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model. Europace (2012) 1.45
Atrial fibrillation begets trouble. Heart (1997) 1.43
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Europace (2010) 1.43
Expression changes of ionic channels in early phase of cultured rat atrial myocytes induced by rapid pacing. J Cardiothorac Surg (2013) 1.42
Mechanisms contributing to myocardial potassium channel diversity, regulation and remodeling. Trends Cardiovasc Med (2015) 1.42
Early versus late atrial fibrillation after atrial flutter ablation. J Interv Card Electrophysiol (2002) 1.42
Termination of atrial fibrillation using pulsed low-energy far-field stimulation. Circulation (2009) 1.41
Cardiac magnetic resonance for prediction of arrhythmogenic areas. Trends Cardiovasc Med (2015) 1.39
Present treatment options for atrial fibrillation. Postgrad Med J (2003) 1.37
Noninvasive electrocardiographic imaging of arrhythmogenic substrates in humans. Circ Res (2013) 1.36
Autonomic nerve activity and atrial fibrillation. Heart Rhythm (2006) 1.33
The stepwise ablation approach for chronic atrial fibrillation--evidence for a cumulative effect. J Interv Card Electrophysiol (2006) 1.30
Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol (2008) 1.29
Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation. Circulation (2013) 1.29
Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol (2009) 1.28
Computational mapping identifies localized mechanisms for ablation of atrial fibrillation. PLoS One (2012) 1.28
The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation: implications for electrogram-based catheter ablation. Circ Res (2011) 1.27
Cellular bases for human atrial fibrillation. Heart Rhythm (2008) 1.25
Patterns of baseline autonomic nerve activity and the development of pacing-induced sustained atrial fibrillation. Heart Rhythm (2010) 1.23
Functional characterization of a Ca(2+)-activated non-selective cation channel in human atrial cardiomyocytes. J Physiol (2004) 1.22
White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol (2011) 1.22
Lone atrial fibrillation: does it exist? J Am Coll Cardiol (2014) 1.21
Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. Am J Physiol Heart Circ Physiol (2006) 1.20
Atrial-selective sodium channel blockers: do they exist? J Cardiovasc Pharmacol (2008) 1.18
Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol (2013) 1.14
Atrial-selective sodium channel block for the treatment of atrial fibrillation. Expert Opin Emerg Drugs (2009) 1.12
Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium. Circ Arrhythm Electrophysiol (2012) 1.12
Atrial fibrillation: the most common arrhythmia. Tex Heart Inst J (2000) 1.11
Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol (2011) 1.10
Termination of sustained atrial flutter and fibrillation using low-voltage multiple-shock therapy. Heart Rhythm (2010) 1.09
Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol (2012) 1.08
Arrhythmias and vagus nerve stimulation. Heart Fail Rev (2011) 1.07
Atrial fibrillation in congestive heart failure. Heart Fail Clin (2010) 1.07
Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation. J Mol Cell Cardiol (2009) 1.06
Electrophysiological remodeling in heart failure. J Mol Cell Cardiol (2010) 1.05
Atrial fibrillation: basic mechanisms, remodeling and triggers. J Interv Card Electrophysiol (2005) 1.05
Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res (2009) 1.05
The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications. Cardiovasc Res (2010) 1.05
Benchmarking electrophysiological models of human atrial myocytes. Front Physiol (2013) 1.05
Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. J Electrocardiol (2009) 1.04
Calmodulin kinase II, sarcoplasmic reticulum Ca2+ leak, and atrial fibrillation. Trends Cardiovasc Med (2010) 1.02
Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients. Heart (2004) 1.01
Critical mass hypothesis revisited: role of dynamical wave stability in spontaneous termination of cardiac fibrillation. Am J Physiol Heart Circ Physiol (2005) 1.01
Re-expression of alpha skeletal actin as a marker for dedifferentiation in cardiac pathologies. J Cell Mol Med (2009) 1.01
Left versus right atrial difference in dominant frequency, K(+) channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery. Heart Rhythm (2009) 1.00
External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart (1999) 1.00
Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation. Heart (2000) 0.99
A three-dimensional human atrial model with fiber orientation. Electrograms and arrhythmic activation patterns relationship. PLoS One (2013) 0.99
Mathematical approaches to understanding and imaging atrial fibrillation: significance for mechanisms and management. Circ Res (2014) 0.99
Hydrogen peroxide modulates the Kv1.5 channel expressed in a mammalian cell line. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.99
Role of repolarization restitution in the development of coarse and fine atrial fibrillation in the isolated canine right atria. J Cardiovasc Electrophysiol (2005) 0.99
Atrial volume reduction following catheter ablation of atrial fibrillation and relation to reduction in pulmonary vein size: an evaluation using magnetic resonance angiography. J Interv Card Electrophysiol (2005) 0.99
Effects of electrical and structural remodeling on atrial fibrillation maintenance: a simulation study. PLoS Comput Biol (2012) 0.98
Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation. Circ Res (2014) 0.97
Triggers and anatomical substrates in the genesis and perpetuation of atrial fibrillation. Curr Cardiol Rev (2012) 0.95
The Role of Inhibitory G Proteins and Regulators of G Protein Signaling in the in vivo Control of Heart Rate and Predisposition to Cardiac Arrhythmias. Front Physiol (2012) 0.95
n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling. Br J Pharmacol (2006) 0.95
Perspective: a dynamics-based classification of ventricular arrhythmias. J Mol Cell Cardiol (2015) 0.95
Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Ther (2011) 0.94
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm (2016) 0.94
Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.94
The future of atrial fibrillation therapy: intervention on heat shock proteins influencing electropathology is the next in line. Neth Heart J (2015) 0.94
Decreased sarcolipin protein expression and enhanced sarco(endo)plasmic reticulum Ca2+ uptake in human atrial fibrillation. Biochem Biophys Res Commun (2011) 0.94
The Na+/K+ pump is an important modulator of refractoriness and rotor dynamics in human atrial tissue. Am J Physiol Heart Circ Physiol (2011) 0.94
Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc (2009) 0.93
Is there a role for remodeled connexins in AF? No simple answers. J Mol Cell Cardiol (2007) 0.92
Left atrial pressure and dominant frequency of atrial fibrillation in humans. Heart Rhythm (2010) 0.92
Impaired kidney function and atrial fibrillation in elderly subjects. J Card Fail (2009) 0.92
Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.92
High-density mapping of electrically induced atrial fibrillation in humans. Circulation (1994) 2.94
Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation (1997) 2.44
Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol (1990) 2.37
Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans. Circulation (1997) 2.29
Sinus node automaticity during atrial fibrillation in isolated rabbit hearts. Circulation (1992) 2.21
Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res (1988) 2.21
Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res (1988) 2.13
Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol (1998) 1.85
Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res (2000) 1.81
Nonlinear analysis of epicardial atrial electrograms of electrically induced atrial fibrillation in man. J Cardiovasc Electrophysiol (1995) 1.56
"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Circulation (2004) 1.48
Circus movement in rabbit atrial muscle as a mechanism of trachycardia. Circ Res (1973) 1.42
Repetitive electrical remodeling by paroxysms of atrial fibrillation in the goat: no cumulative effect on inducibility or stability of atrial fibrillation. J Cardiovasc Electrophysiol (1999) 1.42
Profibrillatory effects of verapamil but not of digoxin in the goat model of atrial fibrillation. J Cardiovasc Electrophysiol (2000) 1.40
Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation (1997) 1.37
The time sequence of electrical and mechanical activation during spontaneous beating and ectopic stimulation. Eur Heart J (1992) 1.37
The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and potassium. Circ Res (1986) 1.34
Electrophysiologic and arrhythmogenic effects of bupivacaine. A study with high-resolution ventricular epicardial mapping in rabbit hearts. Anesthesiology (1992) 1.29
Reentrant excitation around a fixed obstacle in uniform anisotropic ventricular myocardium. Circulation (1991) 1.27
Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation (2001) 1.27
Electrophysiologic mapping to determine the mechanism of experimental ventricular tachycardia initiated by premature impulses. Experimental approach and initial results demonstrating reentrant excitation. Am J Cardiol (1982) 1.24
Coronary sinus pacing prevents induction of atrial fibrillation. Circulation (1997) 1.23
Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol (1998) 1.22
Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation (1998) 1.21
Differential effects of heptanol, potassium, and tetrodotoxin on reentrant ventricular tachycardia around a fixed obstacle in anisotropic myocardium. Circulation (1991) 1.20
Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol (1990) 1.16
Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice. Neth Heart J (2010) 1.10
Anisotropic conduction and reentry in perfused epicardium of rabbit left ventricle. Am J Physiol (1992) 1.07
Intra-atrial reentry as a mechanism for atrial flutter induced by acetylcholine and rapid pacing in the dog. Circulation (1984) 1.04
Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): standardised reporting for model reproducibility, interoperability, and data sharing. Prog Biophys Mol Biol (2011) 1.03
Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat. Cardiovasc Res (2007) 1.02
Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol (1996) 0.98
Experimental electrophysiology and arrhythmogenicity. Anisotropy and ventricular tachycardia. Eur Heart J (1989) 0.97
Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol (2000) 0.97
Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation. Nucleic Acids Res (2000) 0.95
Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis. Arterioscler Thromb Vasc Biol (2008) 0.95
Atrial fibrillation-induced electrical remodeling in humans: what is the next step? Cardiovasc Res (1999) 0.94
Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation (2000) 0.94
The influence of the atrial myocardium on impulse formation in the rabbit sinus node. Pflugers Arch (1987) 0.93
Anisotropic reentry in a perfused 2-dimensional layer of rabbit ventricular myocardium. Circulation (2000) 0.92
Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res (2000) 0.90
Cardiomyocyte remodelling during myocardial hibernation and atrial fibrillation: prelude to apoptosis. Cardiovasc Res (1999) 0.90
Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization. J Cardiovasc Electrophysiol (2000) 0.88
Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol (2000) 0.88
Impulse propagation from the SA-node to the ventricles. Experientia (1987) 0.85
Sinus node response to premature atrial stimulation in the rabbit studied with multiple microelectrode impalements. Circ Res (1978) 0.85
Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria. Circulation (1999) 0.84
Vulnerability of rabbit atrium to reentry by hypoxia. Role of inhomogeneity in conduction and wavelength. Am J Physiol (1992) 0.84
Electrophysiological effects of acute dilatation in the isolated rabbit heart: cycle length-dependent effects on ventricular refractoriness and conduction velocity. Circulation (1997) 0.84
Evidence for the presence of electrotonic depression of pacemakers in the rabbit atrioventricular node. The effects of uncoupling from the surrounding myocardium. Basic Res Cardiol (1988) 0.83
Direct demonstration of sinus node reentry in the rabbit heart. Circ Res (1979) 0.82
Unravelling the electrical mysteries of atrial fibrillation. Eur Heart J (1996) 0.81
Delivery of cholesteryl-conjugated phosphorothioate oligodeoxynucleotides to Kupffer cells by lactosylated low-density lipoprotein. Biochem Pharmacol (2001) 0.81
Ventricular beats induce variations in cycle length of rapid (type II) atrial flutter in humans. Evidence of leading circle reentry. Circulation (1994) 0.80
Experimental models of arrhythmias: toys or truth? Eur Heart J (1994) 0.80
Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy. J Cardiovasc Electrophysiol (2001) 0.80
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol. J Cardiovasc Electrophysiol (1999) 0.80
Reentrant and focal arrhythmias in low potassium in isolated rabbit atrium. Am J Physiol (1988) 0.78
Mapping of atrial fibrillation. Ann Ist Super Sanita (2001) 0.78
Multichannel storage and display system to record the electrical activity of the heart. Med Biol Eng Comput (1988) 0.78
Reentry in the atrium. Bull Schweiz Akad Med Wiss (1975) 0.78
Preferential depression of conduction around a pivot point in rabbit ventricular myocardium by potassium and flecainide. J Cardiovasc Electrophysiol (2000) 0.78
Interaction of acute ventricular dilatation and d-sotalol during sustained reentrant ventricular tachycardia around a fixed obstacle. Circulation (1994) 0.77
Ventricular response during irregular atrial pacing and atrial fibrillation. Am J Physiol (1990) 0.77
Mechanisms of pharmacologic cardioversion of atrial fibrillation by Class I drugs. J Cardiovasc Electrophysiol (1998) 0.77
The mechanism of supraventricular tachycardia induced by a single premature beat in the isolated left atrium of the rabbit. I. Circus movement as a consequence of unidirectional block of the premature impulse. Recent Adv Stud Cardiac Struct Metab (1975) 0.77
On the mechanisms of ventricular tachycardia acceleration during programmed electrical stimulation. Circulation (1991) 0.77
Spatial correlation analysis of atrial activation patterns during sustained atrial fibrillation in conscious goats. Arch Physiol Biochem (2000) 0.76
Circus movement in atrial muscle as a mechanism of supraventricular tachycardia. J Physiol (Paris) (1972) 0.76
The effect of ouabain on the isolated sinus node preparation of the rabbit studied with microelectrodes. Circ Res (1980) 0.76
Electrophysiology of spiral waves in two dimensions: the role of anisotropy. Ann N Y Acad Sci (1990) 0.76
Is atrial fibrillation sometimes a genetic disease? N Engl J Med (1997) 0.75
Minimally invasive mapping guided surgical treatment of atrial fibrillation. Utopia or near future? Indian Pacing Electrophysiol J (2006) 0.75
Dronedarone in patients with atrial fibrillation. Neth Heart J (2010) 0.75
Spatial correlation analysis of the pharmacological conversion of sustained atrial fibrillation in conscious goats by cibenzoline. Arch Physiol Biochem (2000) 0.75
The role of the sinus node in supraventricular arrhythmias. Prog Clin Biol Res (1988) 0.75
Flecainide widens the excitable gap at pivot points of premature turning wavefronts in rabbit ventricular myocardium. J Cardiovasc Electrophysiol (2001) 0.75
Non-linear time series analysis: methods and applications to atrial fibrillation. Ann Ist Super Sanita (2001) 0.75
[The effect of ectopic atrial stimulation on the sinus node: mapping experiments on the isolated right rabbit atrium]. Verh Dtsch Ges Kreislaufforsch (1977) 0.75
Effects of verapamil, diltiazem and disopyramide on sinus function: a comparison with bepridil. Eur J Pharmacol (1989) 0.75
A concentrically and radially adjustable holder for ten microelectrodes. Pflugers Arch (1974) 0.75
Effects of bepridil on conduction properties of the isolated rabbit sinus node and atrial myocardium. J Cardiovasc Pharmacol (1989) 0.75
The mechanism of supraventricular tachycardia induced by a single premature beat in the isolated left atrium of the rabbit. II. The termination of the tachycardia. Recent Adv Stud Cardiac Struct Metab (1975) 0.75
The effect of heart rate on the membrane responsiveness of rabbit atrial muscle. Pflugers Arch (1976) 0.75
Inhibition of muscarinic potassium current by the class III antiarrhythmic drug RP58866 in guinea-pig atrial myocytes. Pacing Clin Electrophysiol (2000) 0.75